Seven Top Pharma Companies Adopt PhaseV's Machine Learning Technology for Drug Development

Within Two Years of Hitting the Market, PhaseV Solutions are Being Used to Guide Adaptive Trials, Precision Medicine, and Indication Selection Across Multiple Therapeutic Areas BOSTON, Nov. 25, 2024 /PRNewswire/ -- PhaseV, a pioneer in software and machine learning (ML) for advanced...